Tekniska uppgifter om nordichealtheconomics.se
Geo IP ger dig information om bl.a. latitud, longitud och ISP (Internet Service Provider).
Vår GeoIP-tjänst hittade var är värd
nordichealtheconomics.se. För närvarande finns det i Sweden och dess tjänsteleverantör är TBA Media AB .
TBA Media AB
Analys av HTTP-huvudet
HTTP Header-information är en del av HTTP-protokollet som användarens webbläsare skickar till den så kallade
som innehåller information om vad webbläsaren vill ha och kommer att ta emot från webbservern.
Date: Wed, 15 Dec 2021 17:13:59 GMT Content-Type: text/html; charset=UTF-8 Transfer-Encoding: chunked Connection: keep-alive Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie cf-edge-cache: cache,platform=wordpress Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink X-Powered-By: WP Engine X-Cacheable: SHORT Cache-Control: max-age=600, must-revalidate X-Cache: MISS X-Cache-Group: iphone X-Frame-Options: SAMEORIGIN Last-Modified: Wed, 15 Dec 2021 08:42:23 GMT CF-Cache-Status: HIT Age: 28790 Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" Server: cloudflare CF-RAY: 6be14e41f8ed7a48-DUS Content-Encoding: gzip
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
ipv4: IP: 126.96.36.199 ASN: 1257 OWNER: TELE2, EU Country: SE mx: MX preference = 10, mail exchanger = mxtls.expurgate.net. ns: ns.tba.net. ns2.tba.net. soa: ns.tba.net. registry.tba.net. 2021092204 14400 3600 1209600 3600 txt: "MS=ms28681170"
Twitter Linkedin Contact Us Biopharma Excellence News & Events Industry News Articles Press Releases Webinars Events Blog Podcasts Resource Library Thought Leadership Fact Flyers Case Studies White Papers Webinars Infographics Video & Animation Careers Life at PharmaLex Current Opportunities Training Top Bar Search MENU MENU About Us About Us About Us Management Team Our Milestones Corporate Social Responsibility What Our Clients Say About Us Our Services Discovery / Non-clinical Go to Discovery / Non-clinical section >> Strategy and Consulting Integrated Product Development Market Access Scientific Advice Statistical Services Toxicology Services Clinical Development Go to Clinical Development section >> Strategy and Consulting Clinical Program Development Scientific Advice Statistical Services Regulatory Affairs Clinical Trial Applications Global Procedure Management Health Authority / Agency Interaction Regulatory Operations Pharmacovigilance Clinical Trial Safety Support Pharmacovigilance Consulting Quality GxP Services Interim / Contract QA Quality Management Systems Tech Transfer / Scale-up Authorization / Approval Go to Authorization / Approval section >> Strategy and Consulting Market Access Regulatory Affairs CMC Services Global Procedure Management Health Authority / Agency Interaction Marketing and Labeling Activities Regulatory Operations Scientific, Regulatory and Technical Writing Statistical Services Pharmacovigilance EU QPPV / National QPPV Pharmacovigilance Consulting Quality Commercialization Readiness Commissioning, Qualification, and Validation (CQV) GxP Services Interim / Contract QA PAI Readiness Post-approval / Maintenance Go to Post-approval / Maintenance section >> Strategy and Consulting Market Access Regulatory Affairs CMC Services Global End-to-End Outsourcing Global Procedure Management Health Authority / Agency Interaction Marketing and Labeling Activities Mergers and Acquisitions (M&A) Transfers Regulatory Operations Toxicology Services Pharmacovigilance EU QPPV / National QPPV ICSR (Individual Safety Case Report) Management Literature Monitoring & Screening Pharmacovigilance Quality & Compliance Signal Management Quality Commissioning, Qualification, and Validation (CQV) GxP Services Interim / Contract QA Quality Management Systems Medical Affairs Healthcare Compliance and Medical Approval Program Management Go to Program Management section >> Program Management Global End-to-End Outsourcing Global Procedure Management Integrated Product Development Mergers and Acquisitions (M&A) Transfers Featured Expertise Industry Expertise Biopharmaceuticals MedTech Services Service Expertise ATMP / Cell and Gene Therapy COVID-19 Support GxP Services Market Access Pharmacovigilance Consulting Post-Brexit Regulatory Support Statistical Services SMARTPHLEX - technology-enabled services Global Reach Global Reach Contact us Contact us News & Events Industry News Articles Press Releases Webinars Events Blog Podcasts Resource Library Thought Leadership Fact Flyers Case Studies White Papers Webinars Infographics Video & Animation Careers Life at PharmaLex Career Opportunities Training PHARMA LEX Beyond the science Using technology-enabled services to empower decision making and drive efficiency gains Contact us today SMARTPHLEX - Find out more PharmaLex Brings You Biopharma Excellence Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars. Visit Website Post-approval / Maintenance Post Market Product Maintenance: the one-stop global full service solution for pharma & biotech companies MedTech Services Expertise to support you throughout the product lifecycle Post-Brexit Regulatory Support Now that the Brexit transition is over and we can look back, what was the cost to the pharma industry as a result of Brexit and the difficulties with the supply of safe and compliant medicines? PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide. The PharmaLex Group now has over 1700 employees, with 45 offices in 24 countries and more than 1000 satisfied clients worldwide. CONTACT US News & Events We are working on webinars for 2022 . Click here to access all our past webinars 23rd November 2021 PharmaLex with its own panel at Biotech Atelier 2021 Conference 24th September 2021 At Last Digital Transformation is Embraced by the Healthcare Industry 19th August 2021 Data Compliance or Rejection – Are you ready for September 15th? 9th August 2021 Signal Detection 16th July 2021 Log or not log (transform data) that’s the question 1st July 2021 Data Science on Blockchain with R. Part I: Reading the blockchain 23rd June 2021 Enoval et les laboratoires accrédités 7th June 2021 PharmaLex broadens market access and HEOR reach 4th June 2021 Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic 17th May 2021 PharmaLex expands APAC region 23rd April 2021 Contamination Control 8th April 2021 USEFUL LINKS Home Contact us Imprint Data Protection Terms and Conditions Statistics and Data Science RECENT TWEETS PharmaLex @PharmaLexGLOBAL · 9 Dec #Merger // PharmaLex is pleased to welcome @pharmasol . The addition of @pharmasol strengthen pharmacovigilance and business support expertise and diversified customer portfolio Read more: https://www.pharmalex.com/pharmalex-extends-footprint-for-technology-enabled-smart-services-with-new-strategic-partnership/ COVID-19 NEWSLETTER SIGN UP SIGN UP NOW WHAT OUR CLIENTS SAY We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner. Small Medium Sized Company, UK Head of Regulatory Affairs ©2021 PharmaLex GmbH. All rights reserved. Please DO NOT send us event/conference information. We will not respond and these will be deleted immediately. Where are you located? Afghanistan Albania Algeria Armenia Argentina Austria Australia Azerbaijan Bangladesh Belarus Belgium Bosnia and Herzegovina Bolivia Brazil British Virgin Islands Bulgaria Canada Chile China Colombia Costa Rica Croatia Cuba Cyprus Czech Republic Denmark Dominican Republic Ecuador El Salvador Estonia Egypt Spain Finland France Georgia Germany Ghana Greece Honduras Hungary Iceland India Indonesia Israel Ireland Iraq Iran, Islamic Republic of Isle of Man Italy Jamaica Japan Jordan Kazakhstan Korea (North) Korea (South) Kuwait Latvia Lebanon Liechtenstein Lithuania Luxemburg Macao Macedonia, Republic of Malta Malaysia Marshall Islands Mexico Morocco Monaco Moldova Montenegro Myanmar Namibia Netherlands New Zealand Norway Oman Pakistan Palestinian Territory Panama Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Serbia Russian Federation Saudi Arabia Singapore Slovenia Slovakia South Africa Sri Lanka Sudan Sweden Switzerland Syrian Arab Republic (Syria) Taiwan, Republic of China Thailand Tunisia Turkey Ukraine United Arab Emirates United Kingdom United States Uruguay Venezuela (Bolivarian Republic) Vietnam Select your state: --- Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisian
De viktigaste sökorden för nordichealtheconomics.se
requirements non-clinical early guide development from post-approval maintenance activities processes submission planning clinical strategic through post-launch regulatory
URL-analys för nordichealtheconomics.se
https://www.pharmalex.com/log-or-not-log-transform-data-thats-the-question/ https://www.pharmalex.com/covid-19-impact-on-the-pharma-supply-chain/ https://www.pharmalex.com/our-services/clinical-development/interim-contract-qa/ https://www.pharmalex.com/our-services/authorization-approval/pharmacovigilance-consulting/ https://www.pharmalex.com/our-services/discovery-non-clinical/integrated-product-development/ https://www.pharmalex.com/resource-category/webinars/ https://www.pharmalex.com/about-pharmalex/clients/ https://www.pharmalex.com///pharmalex-services/ https://www.pharmalex.com/statistics-and-data-science/ https://www.pharmalex.com/resource-category/fact-flyers/ https://www.pharmalex.com/post-approval-maintenance/ https://www.pharmalex.com/pharmalex-broadens-market-access-and-heor-reach/ https://www.pharmalex.com/our-services/clinical-development/clinical-trial-monitoring/ https://www.pharmalex.com///smartphlex/
Whois är ett protokoll som ger tillgång till registreringsinformation. Du kan få reda på när webbplatsen registrerades, när den kommer att upphöra att gälla och vilka kontaktuppgifter webbplatsen har med hjälp av följande information.
I ett nötskal ingår dessa uppgifter;
# Copyright (c) 1997- The Swedish Internet Foundation.
# All rights reserved. # The information obtained through searches, or otherwise, is protected # by the Swedish Copyright Act (1960:729) and international conventions. # It is also subject to database protection according to the Swedish # Copyright Act. # Any use of this material to target advertising or # similar activities is forbidden and will be prosecuted. # If any of the information below is transferred to a third # party, it must be done in its entirety. This server must # not be used as a backend for a search engine. # Result of search for registered domain names under # the .se top level domain. # This whois printout is printed with UTF-8 encoding. # state: active domain: nordichealtheconomics.se holder: ingnor8253-00001 admin-c: - tech-c: - billing-c: - created: 2011-04-14 modified: 2021-03-15 expires: 2022-04-14 transferred: 2012-03-09 nserver: ns.tba.net nserver: ns2.tba.net dnssec: unsigned delegation registry-lock: unlocked status: ok registrar: www.NameSRS.com REFERRER http://www.nic-se.se REGISTRAR NIC-SE SERVERS SERVER se.whois-servers.net ARGS nordichealtheconomics.se PORT 43 TYPE domain DISCLAIMER Copyright (c) 1997- The Swedish Internet Foundation. All rights reserved. The information obtained through searches, or otherwise, is protected by the Swedish Copyright Act (1960:729) and international conventions. It is also subject to database protection according to the Swedish Copyright Act. Any use of this material to target advertising or similar activities is forbidden and will be prosecuted. If any of the information below is transferred to a third party, it must be done in its entirety. This server must not be used as a backend for a search engine. Result of search for registered domain names under the .se top level domain. This whois printout is printed with UTF-8 encoding. DOMAIN STATUS active ok NAME nordichealtheconomics.se CREATED 2011-04-14 EXPIRES 2022-04-14 NSERVER NS.TBA.NET 188.8.131.52 NS2.TBA.NET 184.108.40.206 OWNER HANDLE ingnor8253-00001 REGISTERED yes
Gå till toppen